Zentera Therapeutics Shanghai Co., Ltd. successful hold investigator meeting for c5ZTCN100

2021-04-24 18:24

➢That meeting was face to face and virtual, which was strongly supported and participated by investigators, GCP officer of each site and management team of vendors.

c5ZTCN100 investigators' meeting was successfully held in Shanghai on April 24, 2021. That meeting was held inperson and virtually, which was strongly attended by investigators, GCP officer of each site and management team of vendors.

This meeting is the first investigators' meeting of ZN-c5 pipeline in China. This was the first step for Zentera to officially enter the clinical research stage in China. It is expected that ZN-c5 will bring new treatment options to Chinese patients.